Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-058408

Chief Product & Tech Officer gave up 581 shares (to pay taxes)

  • Chief Product & Tech Officer acquired 1,964 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Besch Doug Chief Product & Tech Officer 2025-12-19 Option exercise +1,964 71,536 D
Besch Doug Chief Product & Tech Officer 2025-12-19 Shares withheld for taxes −581 $13.51 $7,849 70,955 D
Derivatives
Besch Doug Chief Product & Tech Officer 2025-12-19 Option exercise · Restricted Stock Units −1,964 1,964 D
Loading xslF345X05/wk-form4_1766416032.xml…